Article Details

Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

Retrieved on: 2021-02-04 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry. View article details on hiswai:

Excerpt

To address this, AbSci recently acquired artificial intelligence company, Denovium. By integrating Denovium's AI platform, AbSci can improve its data ...

Article found on: www.forbes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo